GlassScriptPhysician profile
Danish Atwal
NPI 1851704100
$2,161.61
in general payments reported to CMS, 2019-2025
17 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $100 · 2021: $184 · 2022: $499 · 2023: $458 · 2024: $317 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.18 | 2019-2022 | |
| Abbott Laboratories | $260.69 | 2022-2023 | Mitraclip |
| Amgen INC. | $205.65 | 2023-2025 | Repatha, Repatha |
| Medtronic, INC. | $186.78 | 2021-2022 | |
| Recor Medical INC | $182.43 | 2024 | Paradise Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $172.44 | 2022-2024 | Camzyos |
| Acist Medical Systems, INC. | $147.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $126.09 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $116.57 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $109.39 | 2023 | Farxiga |
| Abiomed | $107.15 | 2019 | |
| Heartflow, INC. | $57.01 | 2019 | |
| Pfizer INC. | $49.22 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $48.16 | 2023 | Inpefa |
| Boston Scientific Corporation | $38.66 | 2023 | Watchman Flx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $23.40 | 2022 | |
| B. Braun Interventional Systems INC. | $19.73 | 2025 | Cp Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danish Atwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.